Sandbox: maria

Revision as of 16:23, 10 November 2015 by Maria Villarreal (talk | contribs)
Jump to navigation Jump to search

Medulloblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Medulloblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Sandbox: maria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox: maria

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox: maria

CDC on Sandbox: maria

Sandbox: maria in the news

Blogs on Sandbox: maria

Directions to Hospitals Treating Medulloblastoma

Risk calculators and risk factors for Sandbox: maria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Pathogenesis

  • Medulloblastoma arises from embryonal cells, which are stem cells that are normally involved in development of the fourth ventricle.[1]

Genetics

  • Development of medulloblastoma is the result of multiple genetic mutations.
  • Genes involved in the pathogenesis of medulloblastoma include:
  • CTNNB1
  • PTCH1
  • MLL2
  • SMARCA4
  • DDX3X
  • CTDNEP
  • KDM6A
  • TBR1


Associated Conditions

Gross Pathology

Micropathology

  • On microscopic histopathological analysis, characteristic findings of medulloblastoma include:[2]
  • Small round cell tumor
  • Homer-Wright rosettes
  • On immunohistochemestry analysis, characteristic findings of medulloblastoma include:[3][4][5]
  • MAP2 +ve
  • Synaptophysin +ve
  • NSE +ve/-ve
  • NF +ve/-ve
  • Chromogranin +ve/-ve
  • GFAP +ve/-ve
  • Vimentin +ve
  • Nestin +ve
  • INI1 retained

References

  1. Medulloblastoma. Wikipedia (2015)https://en.wikipedia.org/wiki/Medulloblastoma#Pathogenesis Accessed on November,10 2015
  2. Medulloblastoma. Libre Pathology (2015) http://librepathology.org/wiki/index.php/Medulloblastoma Accessed on November,10 2015
  3. Medulloblastoma. Libre Pathology (2015) http://librepathology.org/wiki/index.php/Medulloblastoma Accessed on November,10 2015
  4. Schmidt C (2015). "Targeted Therapy Makes Inroads in Medulloblastoma". J. Natl. Cancer Inst. 107 (11). doi:10.1093/jnci/djv353. PMID 26538622.
  5. Grisold W, Soffietti R. Neuro-Oncology, Part II, Handbook of Clinical Neurology (Series editors: Aminoff, Boller, Swaab). Elsevier; 2012.


Template:WikiDoc Sources